AU
IONS icon

AlphaGrep UK’s Ionis Pharmaceuticals IONS Stock Holding History

AlphaGrep UK’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Buy
+2,946
New +$222K 0.07% 617

Other funds holding IONS

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AlphaGrep UK's IONS Position: Q2 2026 in Review

AlphaGrep UK opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 2,946 shares worth $234K. The stake represents 0.07% of the portfolio and ranks #617 among its holdings.

477 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • AlphaGrep UK held 2,946 shares of Ionis Pharmaceuticals worth $234K as of Q2 2026.
  • Ionis Pharmaceuticals was a new AlphaGrep UK position in Q2 2026.
  • Ionis Pharmaceuticals made up 0.07% of AlphaGrep UK's portfolio in Q2 2026, its #617 holding.
  • 477 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.